BG Medicine, Inc. (BGMD)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Mar 6, 2026, 4:00 PM EST

9,900% (1Y)

Market Cap	11.00
Revenue (ttm)	1.57M
Net Income (ttm)	-6.96M
Shares Out	11.37M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	450
Average Volume	10,730
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	83.27
RSI	47.16
Earnings Date	n/a

About BG Medicine

BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medici... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2000

Employees 5

Stock Exchange OTCMKTS

Ticker Symbol BGMD

Full Company Profile

Financial Performance

In 2015, BG Medicine's revenue was $1.57 million, a decrease of -43.81% compared to the previous year's $2.79 million. Losses were -$6.96 million, -13.72% less than in 2014.

Financial Statements

News

There is no news available yet.